Brief: Salarius Pharmaceuticals Reports 9 Cents Loss Per Share In Q2

Decoy Therapeutics

08/08/2022 13:34

Aug 8 (Reuters) - Salarius Pharmaceuticals Inc  SLRX.O :
    * SALARIUS PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
    * Q2 LOSS PER SHARE $0.09
    * QTRLY LOSS PER SHARE $0.09
    * SALARIUS PHARMACEUTICALS - COMPLETED PRE-IND MEETING PROCESS WITH FDA,
PROCEEDING WITH PLANS TO FILE IND IN H1 2023 FOR SP-3164

Source text for Eikon:  ID:nGNX5vsh1G 
Further company coverage:  SLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))